
Diabetic patients taking GLP-1s may face increased risk of eye disease, study suggests
Fox News
New research suggests GLP-1 medications like Ozempic and Mounjaro may double the risk of neovascular macular degeneration in diabetic patients, despite benefits for blood sugar control.
"The longer patients were exposed to these medications, the greater their risk appeared to be." "While the risk of developing macular degeneration while on a GLP-1 drug is low, patients should be aware of the possible eye side effects."
A retrospective study conducted from January 2020 to November 2023 included more than 139,000 diabetic patients, some of whom were taking GLP-1s for at least six months and some who were not taking the medications over a three-year period.
More Related News













